TABLE 6.
Groupa | No. of sera | No. (%) of sera reactive with: |
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DbpA |
p41i |
OspC |
VlsE |
BmpA |
p58 PBi | P100 PKo | |||||||||||||
PBib | PBr | PKo | B31b | PBi | PKo | 20047 | PBi | PKo | B31 | PBib | PKob | PKa2 | PBi | PKo | B31 | ||||
EM | 15 | 0 (0.0) | 2 (13.3) | 4 (26.7) | 1 (6.7) | 0 (0.0) | 1 (6.7) | 3 (20.0) | 1 (6.7) | 1 (6.7) | 1 (6.7) | 12 (80.0) | 9 (60.0) | 6 (40.0) | 0 (0.0) | 1 (6.7) | 1 (6.7) | 1 (6.7) | 4 (26.7) |
NB | 50 | 19 (38.0) | 20 (40.0) | 17 (34.0) | 6 (12.0) | 6 (12.0) | 15 (30.0) | 5 (10.0) | 2 (4.0) | 4 (8.0) | 8 (16.0) | 44 (88.0) | 41 (82.0) | 41 (82.0) | 17 (34.0) | 12 (24.0) | 13 (26.0) | 27 (54.0) | 26 (52.0) |
ACA | 10 | 1 (10.0) | 0 (0.0) | 8 (80.0) | 1 (10.0) | 3 (30.0) | 9 (90.0) | 0 (0.0) | 1 (10.0) | 3 (30.0) | 0 (0.0) | 10 (100.0) | 0 (0.0) | 10 (100.0) | 1 (10.0) | 1 (10.0) | 0 (0.0) | 10 (100.0) | 8 (80.0) |
AT | 10 | 7 (70.0) | 1 (10.0) | 9 (90.0) | 2 (20.0) | 5 (50.0) | 8 (80.0) | 4 (40.0) | 1 (10.0) | 5 (50.0) | 3 (30.0) | 10 (100.0) | 2 (20.0) | 9 (90.0) | 5 (50.0) | 2 (20.0) | 4 (40.0) | 9 (90.0) | 9 (90.0) |
Controls | 110 | 2 (1.8) | 2 (1.8) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.9) | 3 (2.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.9) | 2 (1.8) |
For abbreviations, see Table 2, footnote a.
Additional antigen on the IgG line blot assay.